8 Results for "

TGF-β1/Smad3

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "TGF-β1/Smad3" in MCE Product Catalog:

113
113 Publications Verification
Cat. No.: HY-13013
CAS No.: 521984-48-5
Purity:  99.62%
Target:  

TGF-beta/Smad

Research Areas:  

Inflammation/Immunology

SIS3 is a potent and selective inhibitor of Smad3 with an IC50 of 3 μM for Smad3 phosphorylation. SIS3 inhibits the myofibroblast differentiation of fibroblasts by TGF-β1 [1].
loading...
    loading...
113
113 Publications Verification
Cat. No.: HY-100444
CAS No.: 521985-36-4
Purity:  98.11%
Target:  

TGF-beta/Smad

Research Areas:  

Inflammation/Immunology

SIS3 free base is a potent and selective inhibitor of Smad3 phosphorylation. SIS3 free base inhibits the myofibroblast differentiation of fibroblasts by TGF-β1. SIS3 free base does not affect the phosphorylation of Smad2 [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W012977
CAS No.: 624-95-3
Synonyms: DMB; Neohexanol
3,3-Dimethyl-1-butanol (DMB) is an orally active inhibitor of trimethylamine (TMA) and trimethylamine N-oxide (TMAO). 3,3-Dimethyl-1-butanol inhibits the signaling pathway of p65 NF-κB and TGF-β1/Smad3. 3,3-Dimethyl-1-butanol has potential applications in cardiovascular disease (CVD) [1] .
loading...
    loading...
Cat. No.: HY-163536
CAS No.: 3043687-96-0
Target:  

TGF-beta/Smad

Research Areas:  

Inflammation/Immunology

TGF-β1/Smad3-IN-1 (Compound 5aa) is an inhibitor of the TGF-β1/Smad3 signaling pathway(IC50=1.07 μM). TGF-β1/Smad3-IN-1 possesses antifibrotic activity and oral potency [1].
loading...
    loading...
Cat. No.: HY-128439
CAS No.: 2232180-74-2
Purity:  98.71%
Target:  

DYRK

Research Areas:  

Cancer

BT173 is a potent homeodomain interacting protein kinase 2 (HIPK2) inhibitor. BT173 binds to HIPK2 and does not inhibit HIPK2 kinase activity but rather, interfered allosterically with the ability of HIPK2 to associate with Smad3. BT173 attenuates renal fibrosis through suppression of the TGF-β1/Smad3 pathway. BT173 can be studied in research for kidney diseases such as renal fibrosis [1].
loading...
    loading...
Cat. No.: HY-P10363
CAS No.: 1647121-94-5
Target:  

TGF-β Receptor

Research Areas:  

Others

Tiger17 is an effective wound healing agent. Tiger17 is able to induce the secretion of TGF-β1 and acts through the Smad signaling pathway, specifically promoting wound healing by increasing the phosphorylation of Smad2 and Smad3 [1].
loading...
    loading...
Cat. No.: HY-182038
Research Areas:  

Metabolic Disease

TGF-β1/Smad3-IN-2 is an orally active antifibrotic agent. TGF-β1/Smad3-IN-2 has high affinity for VDR and can inhibit the TGFβ/SMAD3 signaling pathway. TGF-β1/Smad3-IN-2 inhibits hepatic stellate cell activation, reduces extracellular matrix deposition, and alleviates liver fibrosis in a bile duct ligation mouse model. TGF-β1/Smad3-IN-2 can be used for the research of liver fibrosis [1].
loading...
    loading...
Cat. No.: HY-W012977R
CAS No.: 624-95-3
Synonyms: DMB (Standard); Neohexanol (Standard)
3,3-Dimethyl-1-butanol (Standard) is the analytical standard of 3,3-Dimethyl-1-butanol (HY-W012977). This product is intended for research and analytical applications. 3,3-Dimethyl-1-butanol (DMB) is an orally active inhibitor of trimethylamine (TMA) and trimethylamine N-oxide (TMAO). 3,3-Dimethyl-1-butanol inhibits the signaling pathway of p65 NF-κB and TGF-β1/Smad3. 3,3-Dimethyl-1-butanol has potential applications in cardiovascular disease (CVD) [1] .
loading...
    loading...